Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
I do not believe that RVX will give us some data for the kidney-issue today. The right time would have been yesterday. I guess todays focus is not on scientific data, but overall way forward for the company and its programmes / trials.
BTW: Hepalink 0,4% red. So nothing to worry about but also nothing to be excited about....
